These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1752347)

  • 41. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1].
    Majkowska L; Czekalski S; Skwira J
    Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microalbuminuria development in short-term IDDM.
    González-Clemente JM; Esmatjes E; Navarro P; Ercilla G; Casamitjana R; Rios M; Levy I; Gomis R; Vilardell E
    Diabetes Res Clin Pract; 1994 May; 24(1):15-23. PubMed ID: 7924882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients.
    Mendola G; Casamitjana R; Gomis R
    Diabetologia; 1989 Mar; 32(3):160-2. PubMed ID: 2526767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus.
    Landin-Olsson M; Nilsson KO; Lernmark A; Sundkvist G
    Diabetologia; 1990 Sep; 33(9):561-8. PubMed ID: 2253834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negative correlation between ICA persistence and beta cell restoration after IDDM diagnosis.
    Manna R; Salvatore M; Scuderi F; Papa G; Marietti G; Greco AV; Ghirlanda G; Gambassi G
    Diabetes Res; 1988 Nov; 9(3):101-3. PubMed ID: 3072142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus.
    Bonfanti R; Bazzigaluppi E; Calori G; Riva MC; Viscardi M; Bognetti E; Meschi F; Bosi E; Chiumello G; Bonifacio E
    Diabet Med; 1998 Oct; 15(10):844-50. PubMed ID: 9796885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus.
    Chan JC; Yeung VT; Chow CC; Ko GT; Mackay IR; Rowley MJ; Zimmet PZ; Cockram CS
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):27-34. PubMed ID: 8803479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural course of remission in IDDM during 1st yr after diagnosis.
    Martin S; Pawlowski B; Greulich B; Ziegler AG; Mandrup-Poulsen T; Mahon J
    Diabetes Care; 1992 Jan; 15(1):66-74. PubMed ID: 1737543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.
    Winocour PH; Jeacock J; Kalsi P; Gordon C; Anderson DC
    Diabetes Res Clin Pract; 1990 Apr; 9(1):23-35. PubMed ID: 2351037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age.
    Borg H; Gottsäter A; Landin-Olsson M; Fernlund P; Sundkvist G
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3032-8. PubMed ID: 11443164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Classification of newly-onset IDDIM and NIDDIM in subjects aged 25-45 years in Sudan.
    Elbagir MN; Eltom MA; Berne C
    J Intern Med; 1998 Dec; 244(6):443-50. PubMed ID: 9893097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males?
    Pozzilli P; Mesturino CA; Crino A; Gross TM; Jeng LM; Visalli N;
    Eur J Endocrinol; 2001 Dec; 145(6):757-61. PubMed ID: 11720901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time course of islet cell antibodies and beta-cell function in non-insulin-dependent stage of type I diabetes.
    Kobayashi T; Itoh T; Kosaka K; Sato K; Tsuji K
    Diabetes; 1987 Apr; 36(4):510-7. PubMed ID: 3545950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1*0501-DQB1*0301 haplotype in Type 1 diabetes mellitus. Belgian Diabetes Registry.
    De Block CE; De Leeuw IH; Rooman RP; Winnock F; Du Caju MV; Van Gaal LF
    Diabet Med; 2000 Aug; 17(8):618-22. PubMed ID: 11073185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
    Kretowski A; Szelachowska M; Kinalska I
    Pol Arch Med Wewn; 1999 Apr; 101(4):323-7. PubMed ID: 10740410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A mathematical model for pattern of change in beta-cell reserve and factors affecting residual reserve within the first 2 years of type 1 diabetes.
    Altuntas Y
    J Endocrinol Invest; 2002 Dec; 25(11):987-92. PubMed ID: 12553560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High genetic risk for IDDM in the Pacific Northwest. First report from the Washington State Diabetes Prediction Study.
    Rowe RE; Leech NJ; Nepom GT; McCulloch DK
    Diabetes; 1994 Jan; 43(1):87-94. PubMed ID: 8262322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics.
    Mandrup-Poulsen T; Nerup J; Stiller CR; Marner B; Bille G; Heinrichs D; Martell R; Dupre J; Keown PA; Jenner MR
    Lancet; 1985 Mar; 1(8429):599-602. PubMed ID: 2857945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.